Transgene Biotek Ltd Share Price (526139)
as on
| Source : BSE
Transgene Biotek Ltd Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
₹4.05₹4.69
5.37%
Downside
9.58%
Upside
52 Week's Low
52 Week's High
₹3.22₹9.224.77%
Downside
114.95%
Upside
| Market Stats | |
| Previous Close | ₹4.48 |
| Open | ₹4.68 |
| Volume | 74.97K |
| Upper Circuit | ₹4.92 |
| Lower Circuit | ₹4.04 |
| Day's Low | ₹4.05 |
| Day's High | ₹4.69 |
| 52 Week Low | ₹3.22 |
| 52 Week High | ₹9.2 |
| Returns % | |
| 1 Month Return | -7.25 % |
| 3 Month Return | + 6.92 % |
| 1 Year Return | -49.32 % |
| 3 Year Return | + 40 % |
| 5 Year Return | -16.1 % |
Transgene Biotek Ltd Stock Fundamentals & Key Indicators
Check Transgene Biotek Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹33.94 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-25.88
Return on capital employed (ROCE)
0Industry PE ratio
53.92
Beta (LTM)
0.17
P/B Ratio
-8.95
Dividend Yield
0PEG Ratio
215.69
Quarterly Earnings Growth YOY
-315
EPS (TTM)
-0.09
Sector
Healthcare
Book Value
1.41
Technical Analysis
Bearish
View Technical Analysis
Transgene Biotek Ltd Stock's Interest Amongst Investors
Transgene Biotek Ltd Stock Valuation
Track how Transgene Biotek Ltd P/E has moved over time to understand its valuation trends.
Transgene Biotek Ltd in the last 5 years
Lowest (-227.67x)
December 31, 2024
Today (-25.88x)
August 20, 2025
Industry (53.92x)
August 20, 2025
Highest (13.23x)
October 8, 2018
Today’s Price to Earnings Ratio: -25.88x
Transgene Biotek Ltd Financial Results
Get the annual and quarterly financial summary of Transgene Biotek Ltd, including revenue, profit, loss and more.
Transgene Biotek Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Transgene Biotek Ltd.
Transgene Biotek Ltd Earnings Results
Transgene Biotek Ltd’s net profit fell -315% since last year same period to ₹0.43Cr in the Q1 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 39.44% jump in its net profits since last 3-months.
Read More about Earnings Results
Transgene Biotek Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Transgene Biotek Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 21.68% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 70.04% | 0.00 | |
| Others | 8.28% | 0.00 |
Transgene Biotek Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Transgene Biotek Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 33.94 | -3.22% | 0.96 | -1 | NA | |
| NA | 26.34 | -16.78% | 0.00 | 1 | 24 | |
| NA | 100.30 | 40.11% | 0.59 | 10 | 199 | |
| NA | 81.85 | 7.43% | 0.00 | 4 | 33 | |
| NA | 9.55 | 20.44% | 0.00 | -2 | 4 |
Insights on Transgene Biotek Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, -0.71 Cr → -0.43 Cr (in ₹), with an average increase of 65.1% per quarter
NO EFFECTRetail Holding Unchanged
Retail Investor holdings remained unchanged at 70.04% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Vimta Labs Ltd has given 271.2% return, outperforming this stock by 231.2%
- NO EFFECT
Against Peers
In the last 1 year, Vimta Labs Ltd has given 171.3% return, outperforming this stock by 220.7%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 21.68% of holdings in Jun 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 1 year, Transgene Biotek stock has moved down by -49.3%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 0.12 Cr → 0.05 Cr (in ₹), with an average decrease of 58.3% per quarter
About Transgene Biotek Ltd
Revenue: ₹0.05Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.43Cr as on June 2025 (Q1 FY26)
Chairperson Name: K Koteswara Rao
| Organisation | Transgene Biotek Ltd |
| Industry | Healthcare |
| CEO | K Koteswara Rao |
| E-voting on shares | Click here to vote |
FAQs
What is Transgene Biotek Ltd share price today?
Transgene Biotek Ltd share price today stands at ₹4.28, Open: ₹4.68, Previous Close: ₹4.48, High: ₹4.69, Low: ₹4.05, 52 Week High: ₹9.2, 52 Week Low: ₹3.22 as on .
How to buy Transgene Biotek Ltd shares ?
To buy Transgene Biotek Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 526139 or Transgene Biotek Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Transgene Biotek Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Transgene Biotek Ltd?
Today's traded volume of Transgene Biotek Ltd is 74.97K. Which means that 74.97K shares of Transgene Biotek Ltd were bought and sold on the stock market during today's trading session.
What is Transgene Biotek Ltd's market cap today?
Today's market capitalisation of Transgene Biotek Ltd is ₹33.94 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Transgene Biotek Ltd?
Transgene Biotek Ltd’s 52 week high is ₹9.2 and 52 week low is ₹3.22. The current share price of Transgene Biotek Ltd is ₹4.28, which is -53.48% down from its 52 week high and 32.92% up from its 52 week low.